from other ancestral groups is consequently less in AA subjects. Because PRS would currently be less useful for AA subjects than for EA subjects, questions arise regarding inequities in clinical application (57). One solution is increased emphasis on collection of genetic samples from diverse populations, especially those of AA. We should note that the sample sizes in both the discovery (MVP) and target (COGA) datasets in these analyses are considerably smaller for AA subjects compared with EA subjects.
